These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 19029273

  • 1. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A, Jacobi AM, Mei H, Hiepe F, Dörner T.
    Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
    [Abstract] [Full Text] [Related]

  • 2. Cellular immunity in systemic lupus erythematosus.
    Boumpas DT, Eleftheriades EG, Tsokos GC.
    In Vivo; 1988 Dec; 2(1):41-5. PubMed ID: 2979815
    [Abstract] [Full Text] [Related]

  • 3. B cell loss leading to remission in severe systemic lupus erythematosus.
    Tarrant TK, Frazer DH, Aya-Ay JP, Patel DD.
    J Rheumatol; 2003 Feb; 30(2):412-4. PubMed ID: 12563705
    [Abstract] [Full Text] [Related]

  • 4. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
    Pan HF, Leng RX, Tao JH, Li XP, Ye DQ.
    Lupus; 2011 Mar; 20(3):227-30. PubMed ID: 21362749
    [Abstract] [Full Text] [Related]

  • 5. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V, Farkas L, Banchereau J.
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [Abstract] [Full Text] [Related]

  • 6. Targeting of B cells in SLE: rationale and therapeutic opportunities.
    Silverman GJ.
    Bull NYU Hosp Jt Dis; 2006 Dec; 64(1-2):51-6. PubMed ID: 17121490
    [Abstract] [Full Text] [Related]

  • 7. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP, Hendriks RW.
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [Abstract] [Full Text] [Related]

  • 8. Persistent expression of autoantibodies in SLE patients in remission.
    Yurasov S, Tiller T, Tsuiji M, Velinzon K, Pascual V, Wardemann H, Nussenzweig MC.
    J Exp Med; 2006 Oct 02; 203(10):2255-61. PubMed ID: 16966430
    [Abstract] [Full Text] [Related]

  • 9. Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
    Sawabe T, Horiuchi T, Koga R, Tsukamoto H, Kojima T, Harashima S, Kikuchi Y, Otsuka J, Mitoma H, Yoshizawa S, Niho Y, Watanabe T.
    Genes Immun; 2003 Mar 02; 4(2):122-31. PubMed ID: 12618860
    [Abstract] [Full Text] [Related]

  • 10. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
    Bell DA.
    J Rheumatol; 1981 Mar 02; 8(2):340-4. PubMed ID: 6971937
    [No Abstract] [Full Text] [Related]

  • 11. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr 02; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 12. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L, Ye Y, Zhang X.
    Sci China Life Sci; 2015 Nov 02; 58(11):1111-25. PubMed ID: 26563177
    [Abstract] [Full Text] [Related]

  • 13. [B lymphocyte-dependent or independent suppressor T cell abnormalities in systemic lupus erythematosus].
    Sakane T, Kotani H, Takada S, Tsunematsu T.
    Nihon Naika Gakkai Zasshi; 1982 Sep 10; 71(9):1237-44. PubMed ID: 6218211
    [No Abstract] [Full Text] [Related]

  • 14. Hormonal modulation of B cell development and repertoire selection.
    Grimaldi CM, Hill L, Xu X, Peeva E, Diamond B.
    Mol Immunol; 2005 May 10; 42(7):811-20. PubMed ID: 15829269
    [Abstract] [Full Text] [Related]

  • 15. B cell biology and dysfunction in SLE.
    Anolik JH.
    Bull NYU Hosp Jt Dis; 2007 May 10; 65(3):182-6. PubMed ID: 17922667
    [Abstract] [Full Text] [Related]

  • 16. Abnormalities of B cell subsets in patients with systemic lupus erythematosus.
    Dörner T, Jacobi AM, Lee J, Lipsky PE.
    J Immunol Methods; 2011 Jan 05; 363(2):187-97. PubMed ID: 20598709
    [Abstract] [Full Text] [Related]

  • 17. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U.
    Dermatol Monatsschr; 1984 Jan 05; 170(2):81-90. PubMed ID: 6202566
    [No Abstract] [Full Text] [Related]

  • 18. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC.
    J Exp Med; 2005 Mar 07; 201(5):703-11. PubMed ID: 15738055
    [Abstract] [Full Text] [Related]

  • 19. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.
    Jacobi AM, Diamond B.
    J Exp Med; 2005 Aug 01; 202(3):341-4. PubMed ID: 16061723
    [Abstract] [Full Text] [Related]

  • 20. Lupus and T cells.
    La Cava A.
    Lupus; 2009 Mar 01; 18(3):196-201. PubMed ID: 19213856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.